Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Embody

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Embody head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 36 · Grade B−

Embody

Visit Embody Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 81 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Embody a bad call — it's best for readers considering injectable glp-1 care who will confirm the current rate and billing term before enrollment. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
66
Supply Reliability
95
83
Transparency
90
94
Access Breadth
93
96
Clinical Oversight
92
83
Track Record
88
68
CoreAge RxBrief Score 94 · 81Embody

Price, coverage & the tracker

CoreAge RxEmbody
Brief Score94/100 (A)81/100 (B−)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Advertised from $69/mo for GLP-1 injections; qualifying plan term and total upfront charge require checkout confirmation

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Advertised from $119/mo for GLP-1/GIP injections; qualifying plan term and total upfront charge require checkout confirmation

CoverageUS only; restrictions by state, confirmed at intakeAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Embody: Advertised injection prices start at $69 for GLP-1 and $119 for GLP-1/GIP treatment. Plans cover 4, 12, 24 or 52 weeks; confirm which commitment qualifies for the headline and the full amount due upfront.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.